Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild ProteinuriaDing Chen, Xiangmei Chen, Jian Liu et al.|Kidney & Blood Pressure Research|2018Cited by 25
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trialJie Wu, Xiangmei Chen, Zhaohui Ni et al.|Journal of Chinese Integrative Medicine|2021Cited by 6
P0394EFFICACY AND SAFETY OF A CHINESE PATENT MEDICINE-SHENYANKANGFU TABLETS FOR PRIMARY GLOMERULONEPHRITIS:A RANDOMISED CONTROLLED TRIALJie Wu, Xusheng Liu, Shuwei Duan et al.|Nephrology Dialysis Transplantation|2020Cited by 0